Skip to main content
. 2012 Jun 28;7(9):1498–1506. doi: 10.2215/CJN.01360212

Table 3.

Adverse events within first 30 days

Adverse Event Control Group EPO-α Group
Intraoperative hypotension 0 2
Intraoperative bleeding 3 0
Postoperative bleeding 1 2
Deep venous thrombosis 0 0
Graft thrombosis 0 1
Lower-extremity ischemia 0 1
Death 0 0

Data are number of patients with adverse event. EPO, erythropoietin.